歡迎光臨源葉生物,登錄 | 注冊 |
當(dāng)前位置: 首頁 > 小分子抑制劑 > PI3K/Akt/mTORsignaling > MELK-8a hydrochloride

瀏覽歷史

S34152

MELK-8a hydrochloride

源葉(MedMol) 98%
  • 英文名:
  • MELK-8a hydrochloride
  • 別名:
  • NVS-MELK8a hydrochloride
  • CAS號:
  • 2096992-20-8
  • 分子式:
  • C25H33ClN6O
  • 分子量:
  • 469.02
  • 核磁/質(zhì)譜:
品牌貨號產(chǎn)品規(guī)格價(jià)格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計(jì)量單位 加入購物車...
源葉(MedMol) S34152-5mg 98% ¥500.00元 >10 - - - EA 加入購物車
源葉(MedMol) S34152-10mg 98% ¥730.00元 >10 - - - EA 加入購物車
源葉(MedMol) S34152-25mg 98% ¥1240.00元 8 - - - EA 加入購物車
源葉(MedMol) S34152-100mg 98% ¥3600.00元 2 - - - EA 加入購物車
大包裝詢價(jià)

提交您的電話號碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)

質(zhì)檢證書(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

  • 產(chǎn)品描述:

    MELK-8a hydrochloride是一種新穎的母體胚胎亮氨酸拉鏈激酶(MELK)抑制劑,其IC50值為2 nM。

  • 靶點(diǎn): IC50: 2 nM (MELK);MELK
  • 體外研究:
    MELK-8a remains very potent (IC50=140 nM) when the ATP concentration in the biochemical assay is shifted from 20 μM to 2 mM. Its potency is well tracked between full-length MELK versus catalytic domain construct (5 nM versus 2 nM). It only inhibits seven off-target kinases in addition to MELK with >85% inhibition of binding at 1 μM demonstrating great selectivity. The compound is at least 90-fold more selective in targeting MELK in all cases. MELK-8a is fairly soluble (0.22 g/L at pH 6.8) and shows a good permeability in the Caco-2 assay. MELK-8a inhibits the growth of MDA-MB-468 cells and MCF-7 cells with an IC50 of approximately 0.06 and 1.2 μM, respectively.
  • 體內(nèi)研究:
    Subcutaneous administration of MELK-8a at 30 mg/kg in C57BL/6 mice results in good plasma exposure. The compound adsorption into the systemic circulation is rapid (Tmax=0.4 h) and peak plasma concentration reaches 6.6 μM. An ascending dose PK study in female athymic nude mice shows that the rate of compound release is maximal at 120 mg/kg and all clearance mechanisms can be saturated at 240 mg/kg. However, when administered orally at 10 mg/kg in C57BL/6 male mice, it shows very poor PK (3.6% oral bioavailability) consistent with very high in vivo clearance.
  • 參考文獻(xiàn):
    1. Touré BB, et al. Toward the Validation of Maternal Embryonic Leucine Zipper Kinase: Discovery, Optimization of Highly Potent and Selective Inhibitors, and Preliminary Biology Insight. J Med Chem. 2016 May 26;59(10):4711-23.
  • 溶解性: soluble  in  DMSO
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.132 ml 10.661 ml 21.321 ml
    5 mM 0.426 ml 2.132 ml 4.264 ml
    10 mM 0.213 ml 1.066 ml 2.132 ml
    50 mM 0.043 ml 0.213 ml 0.426 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。